Developing Enhanced Blood-Brain Barrier Permeability Models: Integrating External Bio-Assay Data in QSAR Modeling

Area of Science:

• Pharmacology
• Computational Chemistry
• Drug Discovery

Background:

• Experimental Blood-Brain Barrier (BBB) permeability models are costly and time-intensive.
• Traditional Quantitative Structure-Activity Relationship (QSAR) models offer an alternative but require improvement.

Purpose of the Study:

• To enhance the predictive accuracy of traditional QSAR models for BBB permeability.
• To integrate public bio-assay data into QSAR modeling for improved drug molecule evaluation.

Main Methods:

• A BBB permeability database of 439 compounds was compiled and split into modeling (341) and validation (98) sets.
• A consensus QSAR modeling workflow with five-fold cross-validation was employed.
• Hybrid QSAR models were developed using chemical descriptors and transporter profiles from published membrane transporter models.

Main Results:

• Consensus QSAR models achieved R(2) = 0.638 (cross-validation) and R(2) = 0.504 (external validation).
• Hybrid models incorporating transporter profiles demonstrated superior predictivity: R(2) = 0.646 (cross-validation) and R(2) = 0.526 (external validation).
• An automatic profiling tool identified external bio-assays correlating with BBB permeability.

Conclusions:

• The developed BBB permeability models aid in the early assessment of new drug candidates.
• Integrating chemical and biological descriptors presents a promising strategy for advancing traditional QSAR models.